These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8405008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
    Umeda F, Watanabe J, Inoue K, Hisatomi A, Mimura K, Yamauchi T, Sako Y, Kunisaki M, Tajiri Y, Nawata H.
    Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N, Kashiwagi A, Nishio Y, Kikkawa R.
    Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
    Kagami A, Ishikawa T, Tada N, Sakamoto T, Mochizuki K, Nagano M, Moriguchi EH, Manabe M.
    Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
    [Abstract] [Full Text] [Related]

  • 11. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 12. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
    Sienra-Pérez JC, Lerman-Garber I, Ahumada-Ayala M, Castañón-Romo C, Cardoso-Saldaña G, Laguna-Castellanos M, Posadas-Romero C.
    Arch Inst Cardiol Mex; 1991 Mar; 61(4):365-73. PubMed ID: 1953212
    [Abstract] [Full Text] [Related]

  • 13. Effect of probucol on serum lipoprotein and apoprotein profiles in renal transplant patients.
    Okubo M, Horii A, Kamata K, Takeuchi Y, Tsukamoto Y, Kobayashi N, Sato K, Kumano K, Endo T.
    Am J Kidney Dis; 1998 Feb; 31(2):356-9. PubMed ID: 9469511
    [Abstract] [Full Text] [Related]

  • 14. Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients.
    Ikeda T.
    Diabetes Care; 1993 May; 16(5):849-50. PubMed ID: 8495635
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
    Simons LA, Nestel PJ, Clifton P, Janus ED, Simons J, Parfitt A.
    Med J Aust; 1992 Nov 02; 157(9):584-9. PubMed ID: 1406416
    [Abstract] [Full Text] [Related]

  • 16. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
    Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, Asayama J, Lipid Intrvention Study in Kyoto.
    Circ J; 2002 Jan 02; 66(1):47-52. PubMed ID: 11999665
    [Abstract] [Full Text] [Related]

  • 17. [Pravastatin effects on lipoproteins, Lp (a), apo B and apo A-1 in patients with primary hypercholesterolemia].
    Novazzi JP, Fonseca FA, Feres MC, da Silva RC, Lima JC, Martinez TL.
    Arq Bras Cardiol; 1994 Jun 02; 62(6):395-8. PubMed ID: 7826229
    [Abstract] [Full Text] [Related]

  • 18. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep 02; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

  • 19. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H.
    Clin Nephrol; 1995 Apr 02; 43(4):268-77. PubMed ID: 7606882
    [Abstract] [Full Text] [Related]

  • 20. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD, Kaufman D, Ritter MC, Subbaiah PV.
    Atherosclerosis; 1990 Oct 02; 84(2-3):145-54. PubMed ID: 2282096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.